Neuralstem (CUR) PT Cut to $4 at Brean Capital, 'Buy' Maintained

Go back to Neuralstem (CUR) PT Cut to $4 at Brean Capital, 'Buy' Maintained

Neuralstem (CUR) Tops Q2 EPS by 1c

August 11, 2016 4:09 PM EDT

Neuralstem (NASDAQ: CUR) reported Q2 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.5 million, versus $2.5 million reported last year.

For earnings history and earnings-related data on Neuralstem (CUR) click here.

... More